Cancer BiologybioRxivPreprint
Targeting Vitamin-D receptor (VDR) by a small molecule antagonist MeTC7 inhibits PD-L1 but controls THMYCN neuroblastoma growth PD-L1 independently
R. K. Singh, K. Kim, R. B. Rowswell-Turner…·R. Moore
This study shows that MeTC7, a VDR antagonist, reduces PD-L1 expression in cancer cells and inhibits neuroblastoma growth independently of PD-L1.
DOI 10.1101/2020.08.16.252940